Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

Interpublic Group (IPG) Stock: What the Omnicom Merger and NYSE Delisting Mean Before Markets Open on November 28, 2025

Interpublic Group (IPG) Stock: What the Omnicom Merger and NYSE Delisting Mean Before Markets Open on November 28, 2025

Interpublic Group of Companies, Inc. is about to disappear from U.S. stock screens. When Wall Street reopens after the Thanksgiving holiday on Friday, November 28, 2025, the IPG ticker will no longer trade on the New York Stock Exchange following the completion of its all‑stock merger with Omnicom Group Inc.. Omnicom Group+2SEC+2
Zscaler (ZS) Stock: 13% Post‑Earnings Slump Sets Up Volatile Open for November 28 – What Investors Should Watch

Zscaler (ZS) Stock: 13% Post‑Earnings Slump Sets Up Volatile Open for November 28 – What Investors Should Watch

Zscaler Inc. heads into Friday’s U.S. pre‑market session under pressure after a sharp post‑earnings sell‑off, despite delivering another “beat and raise” quarter. The cloud‑security specialist closed Wednesday, November 26, at $251.97, down about 13% on the day, trimming its year‑to‑date gain to just under 40% and leaving shares roughly a quarter below their early‑November 52‑week high near $337. FinanceCharts+2Investing.com+2
Eli Lilly (LLY) Stock Outlook Before Market Open on November 28, 2025: Trillion‑Dollar Pharma in Focus

Eli Lilly (LLY) Stock Outlook Before Market Open on November 28, 2025: Trillion‑Dollar Pharma in Focus

As U.S. markets prepare for a shortened Black Friday session on Friday, November 28, 2025, Eli Lilly and Company will open trading as one of the most closely watched stocks on Wall Street. The drugmaker has just joined the exclusive $1 trillion market‑cap club thanks to explosive demand for its GLP‑1 weight‑loss and diabetes drugs, alongside new momentum in Alzheimer’s disease and oncology.
27 November 2025
1 886 887 888 889 890 903